TWiV 608: Daniel Griffin's COVID-19 clinical report
About this episode
Daniel Griffin updates the clinical situation with COVID-19 patients, followed by analysis of the remedesivir clinical trial results, and answers listener questions.
Hosts: Vincent Racaniello and Rich Condit
Guest: Daniel Griffin
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Pulmonary embolism in COVID-19 (Emerg Inf Dis)
- Patch Study
- Remdesivir in adults with severe COVID-19 (Lancet)
- ACTT remdesivir trial (NIAID)
- Commentary on remdesivir trials (Lancet)
- FDA expected to issue remdesivir EUA (Contaigon Live)
- Recovered COVID-19 patients wrong (Korea Herald)
- Letters read on TWiV 608
- Image credit
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees.
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology